Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich Hi Debbie: CP is often near impossible to diagnose. That's why too many of us have been through years of suffering, tests and procedures before receiving the lousy news. Often, we have normal amylase and lipase levels, fooling the doctors. In my case, a simple blood test gave the answer. That was for trypsinogen. The sample was drawn at the Cleveland Clinic and sent to an outside lab in Utah. Result came back within two weeks. I was trypsinogen deficient and the level was in the known CP range. That was discovered THREE YEARSinto my illness and after seeing over forty specialists at a dozen major hospitals. To further confirm the diagnosis, I underwent a endoscopic ultrasound (EUS) guided pancreatic biopsy with fine needle aspirations. The tissue samples were consistent with a damaged organ. -Ellen Grove lin Square, NY > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich Hi Debbie: CP is often near impossible to diagnose. That's why too many of us have been through years of suffering, tests and procedures before receiving the lousy news. Often, we have normal amylase and lipase levels, fooling the doctors. In my case, a simple blood test gave the answer. That was for trypsinogen. The sample was drawn at the Cleveland Clinic and sent to an outside lab in Utah. Result came back within two weeks. I was trypsinogen deficient and the level was in the known CP range. That was discovered THREE YEARSinto my illness and after seeing over forty specialists at a dozen major hospitals. To further confirm the diagnosis, I underwent a endoscopic ultrasound (EUS) guided pancreatic biopsy with fine needle aspirations. The tissue samples were consistent with a damaged organ. -Ellen Grove lin Square, NY > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich Hi Debbie: CP is often near impossible to diagnose. That's why too many of us have been through years of suffering, tests and procedures before receiving the lousy news. Often, we have normal amylase and lipase levels, fooling the doctors. In my case, a simple blood test gave the answer. That was for trypsinogen. The sample was drawn at the Cleveland Clinic and sent to an outside lab in Utah. Result came back within two weeks. I was trypsinogen deficient and the level was in the known CP range. That was discovered THREE YEARSinto my illness and after seeing over forty specialists at a dozen major hospitals. To further confirm the diagnosis, I underwent a endoscopic ultrasound (EUS) guided pancreatic biopsy with fine needle aspirations. The tissue samples were consistent with a damaged organ. -Ellen Grove lin Square, NY > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 Serum Complex of Trypsin-2 and a 1-antitrypsin: A New Sensitive Marker of Acute Pancreatitis Johan Hedstr?m, M.D*., Jari Leinonen, M.Sc., and Ulf-H?kan Stenman, M.D. Departmetnt of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland Introduction: Pathological intrapancreatic activation of trypsinogen to trypsin occurs in acute pancreatitis (AP). When reaching blood, trypsin-2 forms a complex with a1-antitrypsin (AAT). The trypsin-2-AAT complex can be specifically measured by a recently developed double antibody sandwich assay. Purpose: To estimate the diagnostic and prognostic accuracy of serum determinations of trypsin-2-AAT in AP. Serum CRP, amylase and trypsinogen-2 were used as reference methods. Design: A retrospective study on consecutive patients during March 1992 to November 1993. Setting: Patients treated for AP and other acute abdominal disorders at the Second Department of Surgery at Helsinki University Central Hospital. Methods: 110 patients with AP and 66 patients with acute abdominal diseases of extrapancreatic origin were studied. The final diagnosis of AP was based in findings of upper abdominal pain accompanied by the typical appearance of AP in ultrasonography or computed tomography (CT). Based on the clinical course, AP was classified as mild (n=82) or severe (n=28). Trypinogen-2 and trypsin-2-AAT were determined by time- resolved immunofluorometric assays (IFMA). The upper reference limit was 12 ?g/L. The ability of various tests to differentiate between mild and severe AP and nonpnacreatic disease was estimated on the basis of sensitivity and specificity at clinically relevant cut-off levels and the validity of the test was further evaluated by receiver-operating characteristic (ROC) curve analysis. Results: At admission, all patients with AP had clearly elevated values of trypsin-2-AAT (= 32 ? g/L), whereas only 5% of the controls had such values. In AP, trypsinogen-2 and trypsin-2-AAT increased earlier than CRP and remained elevated longer than amylase. There was also less overlapping between patients with AP and controls for trypsin-2-AAT than for the other markers. Time course profiles of trypsin-2-AAT showed that in severe cases it mostly peaked in the initial sample and slowly decreased during the next days. In patients with mild AP the peak was mostly observed in the second day. Of the markers studied, trypsin-2-AAT showed the best accuracy (largest area under the ROC curve) both in differentiating AP from controls and mild from severe disease. At presentation, trypsin-2-AAT differentiated between mild and severe AP much more accurately than CRP, AUC being 0.82 and 0.73, respectively. Conclusion: Of the markers studied, trypsin-2-AAT displayed the best accuracy for differentiating between AP and extrapancreatic disease as well as for predicting a severe course of the disease at presentation. If available on automated instrumentation and on emergency basis, the assay could markedly improve the diagnosis of this common and potentially lethal disease. Mark E. Armstrong www.top5plus5.com NW Chapter Rep Pancreatitis Association, International Diagnostic Test for CP > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 Serum Complex of Trypsin-2 and a 1-antitrypsin: A New Sensitive Marker of Acute Pancreatitis Johan Hedstr?m, M.D*., Jari Leinonen, M.Sc., and Ulf-H?kan Stenman, M.D. Departmetnt of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland Introduction: Pathological intrapancreatic activation of trypsinogen to trypsin occurs in acute pancreatitis (AP). When reaching blood, trypsin-2 forms a complex with a1-antitrypsin (AAT). The trypsin-2-AAT complex can be specifically measured by a recently developed double antibody sandwich assay. Purpose: To estimate the diagnostic and prognostic accuracy of serum determinations of trypsin-2-AAT in AP. Serum CRP, amylase and trypsinogen-2 were used as reference methods. Design: A retrospective study on consecutive patients during March 1992 to November 1993. Setting: Patients treated for AP and other acute abdominal disorders at the Second Department of Surgery at Helsinki University Central Hospital. Methods: 110 patients with AP and 66 patients with acute abdominal diseases of extrapancreatic origin were studied. The final diagnosis of AP was based in findings of upper abdominal pain accompanied by the typical appearance of AP in ultrasonography or computed tomography (CT). Based on the clinical course, AP was classified as mild (n=82) or severe (n=28). Trypinogen-2 and trypsin-2-AAT were determined by time- resolved immunofluorometric assays (IFMA). The upper reference limit was 12 ?g/L. The ability of various tests to differentiate between mild and severe AP and nonpnacreatic disease was estimated on the basis of sensitivity and specificity at clinically relevant cut-off levels and the validity of the test was further evaluated by receiver-operating characteristic (ROC) curve analysis. Results: At admission, all patients with AP had clearly elevated values of trypsin-2-AAT (= 32 ? g/L), whereas only 5% of the controls had such values. In AP, trypsinogen-2 and trypsin-2-AAT increased earlier than CRP and remained elevated longer than amylase. There was also less overlapping between patients with AP and controls for trypsin-2-AAT than for the other markers. Time course profiles of trypsin-2-AAT showed that in severe cases it mostly peaked in the initial sample and slowly decreased during the next days. In patients with mild AP the peak was mostly observed in the second day. Of the markers studied, trypsin-2-AAT showed the best accuracy (largest area under the ROC curve) both in differentiating AP from controls and mild from severe disease. At presentation, trypsin-2-AAT differentiated between mild and severe AP much more accurately than CRP, AUC being 0.82 and 0.73, respectively. Conclusion: Of the markers studied, trypsin-2-AAT displayed the best accuracy for differentiating between AP and extrapancreatic disease as well as for predicting a severe course of the disease at presentation. If available on automated instrumentation and on emergency basis, the assay could markedly improve the diagnosis of this common and potentially lethal disease. Mark E. Armstrong www.top5plus5.com NW Chapter Rep Pancreatitis Association, International Diagnostic Test for CP > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 9, 2002 Report Share Posted September 9, 2002 Serum Complex of Trypsin-2 and a 1-antitrypsin: A New Sensitive Marker of Acute Pancreatitis Johan Hedstr?m, M.D*., Jari Leinonen, M.Sc., and Ulf-H?kan Stenman, M.D. Departmetnt of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland Introduction: Pathological intrapancreatic activation of trypsinogen to trypsin occurs in acute pancreatitis (AP). When reaching blood, trypsin-2 forms a complex with a1-antitrypsin (AAT). The trypsin-2-AAT complex can be specifically measured by a recently developed double antibody sandwich assay. Purpose: To estimate the diagnostic and prognostic accuracy of serum determinations of trypsin-2-AAT in AP. Serum CRP, amylase and trypsinogen-2 were used as reference methods. Design: A retrospective study on consecutive patients during March 1992 to November 1993. Setting: Patients treated for AP and other acute abdominal disorders at the Second Department of Surgery at Helsinki University Central Hospital. Methods: 110 patients with AP and 66 patients with acute abdominal diseases of extrapancreatic origin were studied. The final diagnosis of AP was based in findings of upper abdominal pain accompanied by the typical appearance of AP in ultrasonography or computed tomography (CT). Based on the clinical course, AP was classified as mild (n=82) or severe (n=28). Trypinogen-2 and trypsin-2-AAT were determined by time- resolved immunofluorometric assays (IFMA). The upper reference limit was 12 ?g/L. The ability of various tests to differentiate between mild and severe AP and nonpnacreatic disease was estimated on the basis of sensitivity and specificity at clinically relevant cut-off levels and the validity of the test was further evaluated by receiver-operating characteristic (ROC) curve analysis. Results: At admission, all patients with AP had clearly elevated values of trypsin-2-AAT (= 32 ? g/L), whereas only 5% of the controls had such values. In AP, trypsinogen-2 and trypsin-2-AAT increased earlier than CRP and remained elevated longer than amylase. There was also less overlapping between patients with AP and controls for trypsin-2-AAT than for the other markers. Time course profiles of trypsin-2-AAT showed that in severe cases it mostly peaked in the initial sample and slowly decreased during the next days. In patients with mild AP the peak was mostly observed in the second day. Of the markers studied, trypsin-2-AAT showed the best accuracy (largest area under the ROC curve) both in differentiating AP from controls and mild from severe disease. At presentation, trypsin-2-AAT differentiated between mild and severe AP much more accurately than CRP, AUC being 0.82 and 0.73, respectively. Conclusion: Of the markers studied, trypsin-2-AAT displayed the best accuracy for differentiating between AP and extrapancreatic disease as well as for predicting a severe course of the disease at presentation. If available on automated instrumentation and on emergency basis, the assay could markedly improve the diagnosis of this common and potentially lethal disease. Mark E. Armstrong www.top5plus5.com NW Chapter Rep Pancreatitis Association, International Diagnostic Test for CP > I am scheduled to see our local GI doctor on Sept 25 and also have an appt at > U of Mich w/GI doctor there. Are there any specific tests that they should be > doing on me to test for CP or other problems with the pancreas, such as > pancreatic insufficiency? I have not been diagnosed w/CP only acute > Pancreatitis in April-02 after I had already had 4 other attacks on a monthly > basis - but I did not know what they were and did not go to ER. But since > July I have been having some right upper quandrant pain that radiates to my > back and moves around to the left. Is there a list of tests they should be > doing? Any suggestions would be appreciated. > Debbie in Mich > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.